Category: Include on Menu
-
Arbutus Biopharma shares jump after unveiling $230 million share buyback plan
Arbutus Biopharma Corporation (NASDAQ:ABUS) shares climbed 10.3% in premarket trading on Friday after the biotechnology company announced plans to repurchase up to $230 million of its common stock through a modified Dutch auction tender offer. The proposed buyback will give shareholders the opportunity to tender their shares for cash at a price ranging from $5.00…
-
Modine shares climb after Hunterbrook highlights data centre cooling opportunity
Modine (NYSE:MOD) shares rose more than 5% in pre-market trading on Friday after Hunterbrook Media published a bullish report suggesting the company’s data centre cooling opportunity could be substantially larger than its public disclosures currently imply. Hunterbrook said its affiliated investment firm holds a long position in Modine and pointed to internal planning information discovered…
-
Milestone Pharmaceuticals shares rise as first patient enters Phase 3 AFib trial
Milestone Pharmaceuticals Inc (NASDAQ:MIST) shares gained 3.9% on Friday after the company announced that the first patient had been enrolled in its Phase 3 ReVeRA-301 study of etripamil for atrial fibrillation with rapid ventricular rate (AFib-RVR). The late-stage trial represents an important step in Milestone’s efforts to expand the potential use of etripamil beyond paroxysmal…
-
Asure Software shares rise as AWS Marketplace listing opens new sales channel
Asure Software Inc (NASDAQ:ASUR) shares gained 3.1% in Friday premarket trading after the payroll and human resources technology provider announced plans to make its payroll tax solutions available through Amazon Web Services Marketplace from September. The move will allow Asure to co-sell its Enterprise Payroll Tax and Treasury products to AWS Marketplace’s network of approximately…
-
Werewolf Therapeutics shares surge 120% after Ambros merger and $150 million financing
Werewolf Therapeutics Inc (NASDAQ:HOWL) shares soared 120% in premarket trading on Friday after the biotechnology company agreed to merge with Ambros Therapeutics Inc alongside a $150 million private placement. The all-stock combination will create a company centred on the development of neridronate, Ambros Therapeutics’ late-stage drug candidate for Complex Regional Pain Syndrome Type 1 (CRPS-1).…
-
JPMorgan says stronger AI revenue makes capex boom more economically viable
JPMorgan believes faster revenue growth across the artificial intelligence industry is making the huge wave of infrastructure investment underpinning the sector look increasingly sustainable from an economic perspective. “The recent acceleration in AI companies’ revenues makes the AI capex cycle look more economically viable than it did six months ago,” strategist Nikolaos Panigirtzoglou wrote in…
-
Nvidia in advanced talks to invest hundreds of millions in Cloverleaf Infrastructure – WSJ
Nvidia (NASDAQ:NVDA) is reportedly in advanced negotiations to invest several hundred million dollars in Cloverleaf Infrastructure, a power development company specialising in securing electricity capacity for data-centre projects, according to The Wall Street Journal. An agreement could be announced as soon as Friday. Although Cloverleaf is privately held, a transaction would carry strategic significance for…
-
Wall Street futures point to rebound after Thursday’s sharp selloff: Dow Jones, S&P, Nasdaq
US stock futures moved higher on Friday, signalling a potential rebound at the opening bell after Wall Street suffered steep losses in the previous session amid rising oil prices and renewed pressure from bond yields. Investors appeared willing to return to stocks following Thursday’s decline, although continued strength in crude oil and uncertainty surrounding the…
-
Wolfe Research highlights powerful S&P 500 earnings momentum
S&P 500 companies are delivering strong second-quarter results, with Wolfe Research pointing to widespread revenue beats, upbeat guidance and an unusually robust earnings growth outlook for 2026. According to the research firm, 465 companies in the S&P 500 had reported their second-quarter 2026 results through Wednesday. Of those, 69% exceeded consensus revenue forecasts, with the…
-
US regulatory momentum seen as key driver behind Bitcoin breakout
Bitcoin’s (COIN:BTCUSD) move out of its recent trading range appears to have been driven primarily by improving US regulatory sentiment rather than broader concerns about currency debasement, according to Citi analysts. The bank pointed to the delayed reaction in Bitcoin following the US Treasury’s bond buyback announcement, as well as ether outperforming Bitcoin during the…